Antibiotic Resistance Lab Network
Antibiotic Resistance Lab Network
The Antibiotic Resistance Lab Network (ARLN) is a national initiative in the United States aimed at detecting, responding, and preventing antibiotic resistance. The network is coordinated by the Centers for Disease Control and Prevention (CDC) and involves public health labs across seven regions in the country.
Overview
The ARLN was established in 2016 as part of the CDC's broader efforts to combat antibiotic resistance. The network's primary goal is to rapidly detect and respond to antibiotic resistance threats in healthcare, food, and the community. It also aims to support local and state health departments in their efforts to prevent the spread of resistant infections.
Functions
The ARLN performs several key functions:
- Detection: The network uses advanced molecular biology techniques to identify resistant bacteria. This includes whole genome sequencing and other genomic methods.
- Response: When a resistant strain is detected, the ARLN works with healthcare providers, infection control professionals, and public health departments to respond effectively.
- Prevention: The network also supports prevention efforts, such as infection control and antibiotic stewardship programs.
Regional Labs
The ARLN consists of seven regional labs, each serving a specific geographic area. These labs are located in California, Minnesota, New York, Tennessee, Texas, Washington, and Wisconsin. Each lab has a specific focus area, such as carbapenem-resistant Enterobacteriaceae (CRE), Candida auris, or Neisseria gonorrhoeae.
Impact
Since its inception, the ARLN has played a crucial role in detecting and responding to antibiotic resistance threats. It has helped identify numerous outbreaks and has supported the implementation of effective prevention strategies.
See Also
- Antibiotic resistance
- Centers for Disease Control and Prevention
- Molecular biology
- Whole genome sequencing
- Infection control
- Antibiotic stewardship
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen
